3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
28
Burkitt Lymphoma
20
Leukemia, Myeloid, Acute
11
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
7
Myeloproliferative Disorders
5
Myelodysplastic Syndromes
5
Lymphoma, Non-Hodgkin
5
Lymphoma, Mantle-Cell
5
Lymphoma, Large B-Cell, Diffuse
5
Leukemia, Myelomonocytic, Chronic
5
Leukemia, Myeloid, Accelerated Phase
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Leukemia, Biphenotypic, Acute
5
Hodgkin Disease
5
Congenital Abnormalities
5
Lymphoma, Large-Cell, Anaplastic
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Blast Crisis
4
Anemia, Refractory, with Excess of Blasts
4
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Lymphoma
3
Hematologic Neoplasms
3
Chromosome 5q Deletion Syndrome
3
Breast Neoplasms
3
Waldenstrom Macroglobulinemia
2
Sezary Syndrome
2
Recurrence
2
Primary Myelofibrosis
2
Interventions
Ifosfamide
11
Methotrexate
9
Doxorubicin
7
Magnetic Resonance Spectroscopy
6
Filgrastim
6
Cisplatin
6
Leucovorin
5
Etoposide
5
X-Rays
4
Specimen Handling
4
Sirolimus
4
Phantoms, Imaging
4
Gemcitabine
4
temsirolimus
3
sargramostim
3
dinutuximab
3
cixutumumab
3
Radiotherapy
3
Nuclear Medicine Department, Hospital
3
Granulocyte-Macrophage Colony-Stimulating Factor
3
Dexrazoxane
3
Cyclophosphamide
3
Biopsy
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
samarium Sm-153 lexidronam
2
palbociclib
2
olaparib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Osteosarcoma
×
merphos
×
Clear all
NCT00134030
2023-06-07
EURAMOS-1
Children's Oncology Group
Phase 3
Completed
1,334 enrolled
17 charts